FULC
Price
$10.14
Change
-$0.24 (-2.31%)
Updated
Jan 16 closing price
Capitalization
668.94M
39 days until earnings call
Intraday BUY SELL Signals
NUVB
Price
$5.85
Change
-$0.29 (-4.72%)
Updated
Jan 16 closing price
Capitalization
2.01B
46 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

FULC vs NUVB

Header iconFULC vs NUVB Comparison
Open Charts FULC vs NUVBBanner chart's image
Fulcrum Therapeutics
Price$10.14
Change-$0.24 (-2.31%)
Volume$1.28M
Capitalization668.94M
Nuvation Bio
Price$5.85
Change-$0.29 (-4.72%)
Volume$5.4M
Capitalization2.01B
FULC vs NUVB Comparison Chart in %
FULC
Daily Signal:
Gain/Loss:
NUVB
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
FULC vs. NUVB commentary
Jan 19, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FULC is a Hold and NUVB is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 19, 2026
Stock price -- (FULC: $10.14 vs. NUVB: $5.85)
Brand notoriety: FULC and NUVB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FULC: 78% vs. NUVB: 68%
Market capitalization -- FULC: $668.94M vs. NUVB: $2.01B
FULC [@Biotechnology] is valued at $668.94M. NUVB’s [@Biotechnology] market capitalization is $2.01B. The market cap for tickers in the [@Biotechnology] industry ranges from $111.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FULC’s FA Score shows that 1 FA rating(s) are green whileNUVB’s FA Score has 0 green FA rating(s).

  • FULC’s FA Score: 1 green, 4 red.
  • NUVB’s FA Score: 0 green, 5 red.
According to our system of comparison, both FULC and NUVB are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FULC’s TA Score shows that 3 TA indicator(s) are bullish while NUVB’s TA Score has 5 bullish TA indicator(s).

  • FULC’s TA Score: 3 bullish, 7 bearish.
  • NUVB’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, NUVB is a better buy in the short-term than FULC.

Price Growth

FULC (@Biotechnology) experienced а +2.94% price change this week, while NUVB (@Biotechnology) price change was -27.24% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.24%. For the same industry, the average monthly price growth was +4.14%, and the average quarterly price growth was +42.40%.

Reported Earning Dates

FULC is expected to report earnings on Feb 26, 2026.

NUVB is expected to report earnings on Mar 05, 2026.

Industries' Descriptions

@Biotechnology (+1.24% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NUVB($2.01B) has a higher market cap than FULC($669M). FULC YTD gains are higher at: -10.345 vs. NUVB (-34.710). FULC has higher annual earnings (EBITDA): -80.09M vs. NUVB (-208.96M). NUVB has more cash in the bank: 549M vs. FULC (201M). FULC has less debt than NUVB: FULC (7.01M) vs NUVB (57.5M). NUVB has higher revenues than FULC: NUVB (26.7M) vs FULC (0).
FULCNUVBFULC / NUVB
Capitalization669M2.01B33%
EBITDA-80.09M-208.96M38%
Gain YTD-10.345-34.71030%
P/E RatioN/AN/A-
Revenue026.7M-
Total Cash201M549M37%
Total Debt7.01M57.5M12%
FUNDAMENTALS RATINGS
FULC: Fundamental Ratings
FULC
OUTLOOK RATING
1..100
69
VALUATION
overvalued / fair valued / undervalued
1..100
28
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
29

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FULCNUVB
RSI
ODDS (%)
Bearish Trend 6 days ago
83%
Bullish Trend 3 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
77%
Momentum
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
89%
MACD
ODDS (%)
Bearish Trend 3 days ago
71%
Bearish Trend 3 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
87%
Bearish Trend 3 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
86%
Advances
ODDS (%)
Bullish Trend 4 days ago
88%
Bullish Trend 28 days ago
81%
Declines
ODDS (%)
Bearish Trend 7 days ago
84%
Bearish Trend 3 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
88%
Aroon
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
FULC
Daily Signal:
Gain/Loss:
NUVB
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IDHIX20.640.05
+0.24%
Integrity Dividend Harvest I
GEMLX16.150.03
+0.19%
Goldman Sachs Emerging Mkts Eq ex. Chn C
DIHRX15.920.01
+0.06%
DFA Intl Hi Relatv Profitability Instl
TVRCX15.11-0.01
-0.07%
NAA Allocation C
TWEAX8.67-0.02
-0.23%
American Century Equity Income A

FULC and

Correlation & Price change

A.I.dvisor indicates that over the last year, FULC has been loosely correlated with WVE. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if FULC jumps, then WVE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FULC
1D Price
Change %
FULC100%
-2.31%
WVE - FULC
55%
Loosely correlated
-2.99%
GPCR - FULC
49%
Loosely correlated
+4.26%
OCUL - FULC
49%
Loosely correlated
-0.09%
SLS - FULC
48%
Loosely correlated
+3.65%
KRRO - FULC
43%
Loosely correlated
-0.23%
More

NUVB and

Correlation & Price change

A.I.dvisor indicates that over the last year, NUVB has been loosely correlated with NRIX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if NUVB jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NUVB
1D Price
Change %
NUVB100%
-4.72%
NRIX - NUVB
45%
Loosely correlated
+1.86%
VCYT - NUVB
40%
Loosely correlated
+1.39%
ANNX - NUVB
39%
Loosely correlated
-1.46%
FATE - NUVB
39%
Loosely correlated
+13.33%
FULC - NUVB
38%
Loosely correlated
-2.31%
More